Photobiomodulation Therapy for Long Covid-19

According to the National Center for Health Statistics, as of mid-2024, approximately 30% of those who have had COVID report having long COVID, and 10% report they still have long COVID. Long COVID varies greatly from person to person, and there is a very wide range of symptoms, from cardiorespiratory to neuropsychological issues. For some people, their symptoms are extremely debilitating and prevent them from normal functioning in daily life, which also increases their risk of developing chronic conditions, such as diabetes, heart disease, kidney disease, neuropathy, etc.

Even though everyone wants to forget about COVID, those in clinical practice know that these long COVID-related symptoms or conditions are not going away in the patient population, and, unfortunately, there actually seems to be an increase in them. Photobiomodulation therapy (PBMT) has shown to be an effective treatment in combination with oxygen therapies, molecular hydrogen therapy, and targeted nutritional and herbal therapeutic agents.

Loss of taste and smell is the hallmark symptom for most people who have COVID, and, for a subset of these people, they never regained their normal olfactory and gustatory function. Multiple research articles were published in 2023 about using PBMT to restore normal function.